The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Sarcopenia: revised European consensus on definition and diagnosis
Open accessAbstract
Background: in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives: to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations: sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions: EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These variables are critical indicators of mobility, independence, and fall risk in older adults [3].”
From Efficacy of Power Training on Sarcopenic Obesity in Community-Dwelling Older Women: A 32-Week Randomized Clinical Trial (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These individuals—and especially women and those with T2D, prediabetes, or metabolic dysfunction‐associated steatotic liver disease (MASLD)—are already at high risk of sarcopenia (age‐related loss of skeletal muscle function and mass), 30 , 31 sarcopenic obesity (the co‐existence of excess adiposity and low muscle mass/function, which can occur at any age 32 ), and the serious negative health out”
From Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenia definitions have evolved through European and Asian consensus updates that place greater emphasis on muscle strength and physical performance, while the ESPEN and EASO consensus and the Sarcopenic Obesity Global Leadership Initiative have attempted to standardize SO diagnosis and research priorities (2, 7–9).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, a major reason for the variation in sarcopenic obesity prevalence is the method of adjusting muscle quantity for body size.46,47,55,57”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All regional working groups on the definition of sarcopenia have moved from recommending using lean mass alone to adding muscle strength and function, and switching the focus of the definition from lean mass to muscle strength and function.[46][47][48]”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [46]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“The updated definition of sarcopenia elevated low muscle strength to the forefront as a primary indicator of sarcopenia and identified poor physical performance as indicative of severe sarcopenia (52).”
From Evolution of the diagnosis of malnutrition in adults: a primer for clinicians (2024) · cites this paper as [52]
In the citing paper
“In this revised consensus, low physical performance is proposed as an indicator of severe sarcopenia.”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [19]
In the citing paper
“Notably, the EWGSOP2 reported low muscle strength as a key characteristic of sarcopenia to facilitate the prompt identification of sarcopenia in practice (19).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [19]
In the citing paper
“the updated EWGSOP2 guidelines that focused on low muscle strength using grip strength as a central factor for diagnosing sarcopenia, as muscle strength has been shown to better predict poor outcomes than muscle mass in sarcopenia (3–5).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [3]
In the citing paper
“Therefore, the adverse effects of sarcopenia on quality of life, health care demand, morbidity, and mortality can affect both middle‐aged and older‐aged adults. 1 , 2 , 6”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“but the decline in muscle mass starts from ~40 years onwards. 1”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“Sarcopenia is a progressive and complex disease associated with a higher burden of morbidity and mortality. 1 , 2 , 6”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“The revised EWGSOP2 emphasizes that severe sarcopenia should be based on the combination of sarcopenia plus a low physical performance, such as slow gait speed. 1”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“Nowadays, it is known that the decrease in muscle mass function and quality start at ~40 years and that sarcopenia often appears earlier in life. 1 , 2”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“the biggest impact is likely to be on prevalence estimated using EWGSWOP2 1 as well as the AWGS that updated its sarcopenia definition and its cut‐off points in March 2020. 33”
From Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis (2022) · cites this paper as [1]
In the citing paper
“although the effect of obesity on years-of-life-lost is greatest in younger adults, and the magnitude of years lost with obesity decreases with ageing [16], irrespective of sex, smoking status, physical activity level, or socioeconomic status [35]”
From Obesity pharmacotherapy in older adults: a narrative review of evidence (2025) · cites this paper as [35]
In the citing paper
“Sarcopenia, defined as low skeletal muscle mass and function, has been identified and described as a geriatric syndrome with a multifactorial aetiology whose prevalence increases with age [3-5].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [5]
In the citing paper
“This definition was revised in 2019 to describe sarcopenia as “a muscle disease originating from adverse muscle changes that accumulate over a lifetime”.”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“The recent guidelines from EWGSOP have made slight modifications to previous diagnostic cutoff values, proposing an ALMI < 5.5 kg/m2 in women and ALMI < 7.0 kg/m2 in men be used as criteria for defining low muscle mass (1).”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“EWGSOP proposes a screening and diagnostic approach for sarcopenia termed “Find-Assess-Confirm-Severity” (F-A-C-S; Figure 1).1”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“Among the strategies for preserving muscle quantity and quality, resistance exercise training is a reliable approach.1”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [1]
In the citing paper
“This is of particular concern in older adults, where muscle loss contributes to frailty, impaired glucose regulation, increased fall risk, and decreased quality of life [33].”
From Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes (2025) · cites this paper as [33]
In the citing paper
“fatigue and grip strength are also well-established measures of sarcopenia and physical frailty54,55 and are commonly used to assess the pathological impairment of quality of life in older people in clinical practice.”
From Trigonelline Is an NAD+ Precursor That Improves Muscle Function during Ageing and Is Reduced in Human Sarcopenia (2024) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 1×
“For the TUG test, individuals are asked to rise from a standard chair, walk to a marker 3 m away, turn around, walk back and sit down again [89].”
MethodSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Self-citationClegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
A global clinical measure of fitness and frailty in elderly people
Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I. G., Bruera, E. D., Fainsinger, R. L., Jatoi, A., Loprinzi, C. L., Macdonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 6,020
Gait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558 · cited 1×
“…<7.0 kg/m2 <6.0 kg/m2 Gould (2014) [125] EWGSOP2 sarcopenia cut-off points for low performance Gait speed ≤0.8 m/s Cruz-Jentoft (2010) [1] Studenski (2011) [84] SPPB ≤8 point score Pavasini (2016) [90] Guralnik (1995) [126] TUG ≥20 s Bischoff (2003) [127] 400 m walk test Non-completion…”
BackgroundInfluentialFrailty Consensus: A Call to Action
Morley, J. E., Vellas, B. J., van Kan, G. A., Anker, S. D., Bauer, J. M., Bernabei, R., Cesari, M., Chumlea, W. C., Doehner, W., Evans, J., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.03.022 · Cited by 4,201
Self-citationLower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320902 · Cited by 4,083
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Flagged first, then by citations
2 of the 156 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Keller, 2018, Sarcopenia, Wien Med Wochenschr
Cited by
Sorted by citations
Items 901–1,000 of 1,118
Mallard, J., Hucteau, E., Hureau, T. J., & Pagano, A. F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.719643 · Cited by 62
The Therapeutic Intervention of Sex Steroid Hormones for Sarcopenia
Huang, L., & Wang, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.739251 · Cited by 64
Wallengren, O., Bosaeus, I. G., Frändin, K., Lissner, L., Falk, H., Wetterberg, H., Sterner, T. R., Rydén, L., Rothenberg, E. M., & Skoog, I. G. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02533-y · Cited by 59
Toward the recognition and management of sarcopenia in routine clinical care
Dent, E., Woo, J., Scott, D. S., & Hoogendijk, E. O. (2021) · Nature Aging · doi:10.1038/s43587-021-00136-1 · Cited by 57
Protein and Sport: Alternative Sources and Strategies for Bioactive and Sustainable Sports Nutrition
López-Martínez, M. I., Miguel, M., & Garcés‐Rimón, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.926043 · Cited by 90
Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
Iwaki, M., Kobayashi, T., Nogami, A., Saito, S., Nakajima, A., & Yoneda, M. (2023) · Nutrients · doi:10.3390/nu15040891 · Cited by 61
The bioelectrical impedance analysis (BIA) international database: aims, scope, and call for data
Silva, A. M., Campa, F., Stagi, S., Gobbo, L. A., Buffa, R., Toselli, S., Silva, D. A. S., Gonçalves, E. M., Langer, R. D., Guerra‐Júnior, G., et al. (2023) · European Journal of Clinical Nutrition · doi:10.1038/s41430-023-01310-x · Cited by 66
Obesity paradox in older sarcopenic adults ― a delay in aging: A systematic review and meta-analysis
Eitmann, S., Mátrai, P., Hegyi, P. J., Balaskó, M., Erőss, B. M., Dorogi, K., & Pétervári, E. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102164 · Cited by 59
Gómez-Redondo, P., Valenzuela, P. L., Morales, J. S., Ara, I., & Mañas, A. (2024) · Sports Medicine · doi:10.1007/s40279-024-02024-1 · Cited by 66
“This is consistent with the results obtained since, as we age, we tend to lose power, strength, and muscle mass due to the natural phenomenon of sarcopenia [61], so participants may be more likely to improve outcomes such as knee extension strength or STS if their baseline level is low.”
ResultGroothof, D., Shehab, N. B. N., Erler, N. S., Post, A., Kremer, D., Polinder‐Bos, H. A., Gansevoort, R. T., Groen, H., Pol, R. A., Gans, R. O. B., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13511 · Cited by 64
The obesity paradox: A further consideration in dialysis patients
Kittiskulnam, P., & Johansen, K. L. (2019) · Seminars in Dialysis · doi:10.1111/sdi.12834 · Cited by 56
Biomarkers of sarcopenia in very old patients with hip fracture
Sánchez-Castellano, C., Martín‐Aragón, S., Bermejo‐Bescós, P., Vaquero-Pinto, N., Miret-Corchado, C., de Miguel, A. M., & Cruz-Jentoft, A. J. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12508 · Cited by 58
Self-citationBiomarkers Profile of People With Sarcopenia: A Cross-sectional Analysis From UK Biobank
Petermann-Rocha, F. E., Gray, S. R., Pell, J. P., Celis-Morales, C. A., & Ho, F. K. W. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.05.005 · Cited by 56
Calf circumference value for sarcopenia screening among older adults with stroke
Inoue, T., Maeda, K., Shimizu, A., Nagano, A., Ueshima, J., Sato, K., & Murotani, K. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104290 · Cited by 57
Inflammatory potential of the diet and risk of sarcopenia and its components
Bagheri, A., Soltani, S., Hashemi, R., Heshmat, R., Motlagh, A. D., & Esmaillzadeh, A. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00649-2 · Cited by 57
Sarcopenic obesity and health outcomes: An umbrella review of systematic reviews with meta‐analysis
Veronese, N., Ragusa, F. S., Pegreffi, F., Dominguez, L. J., Barbagallo, M., Zanetti, M., & Cereda, E. (2024) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13502 · Cited by 56
“This would be consistent with the operational algorithm for case fi nding and con fi rmation implemented by expert panels for an elderly population, 30 according to which the evaluation of muscle strength and/or performance should come to the forefront as a more relevant determinant of prognosis.”
MethodSarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041917 · Cited by 56
Zebrafish models of sarcopenia
Daya, A., Donaka, R., & Karasik, D. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.042689 · Cited by 55
Alkhedhairi, S. A., Aba Alkhayl, F. F., Ismail, A. D., Rozendaal, A., German, M., MacLean, B., Johnston, L., Miller, A. A., Hunter, A. M., Macgregor, L. J., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.04.007 · Cited by 56
Matsuzawa, R., Yamamoto, S., Suzuki, Y., Imamura, K., Harada, M., Matsunaga, A., Tamaki, A., Fukui, T., & Shimokado, K. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.07.025 · Cited by 58
Mas, M. F., González, J., & Frontera, W. R. (2020) · Current Physical Medicine and Rehabilitation Reports · doi:10.1007/s40141-020-00284-2 · Cited by 58
Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008–2011
Kim, J. A., Hwang, S. Y., Yu, J. H., Roh, E., Hong, S., Lee, Y., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, N. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80305-1 · Cited by 58
Rondanelli, M., Nichetti, M., Peroni, G., Faliva, M. A., Naso, M., Gasparri, C., Perna, S., Oberto, L., Paolo, E. D., Riva, A., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2020.622391 · Cited by 60
Jyväkorpi, S. K., Ramel, A., Strandberg, T. E., Piotrowicz, K., Błaszczyk-Bębenek, E., Urtamo, A., Rempe, H. M., Geirsdóttir, Ó. G., Vágnerová, T., Billot, M., et al. (2021) · European Geriatric Medicine · doi:10.1007/s41999-020-00438-4 · Cited by 60
Self-citationChanges in Body Composition Are Associated with Metabolic Changes and the Risk of Metabolic Syndrome
Oh, Y. H., Choi, S., Lee, G., Son, J. S., Kim, K. H., & Park, S. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040745 · Cited by 63
Artificial intelligence-aided CT segmentation for body composition analysis: a validation study
Borrelli, P., Kaboteh, R., Enqvist, O., et al. (2021) · European Radiology Experimental · doi:10.1186/s41747-021-00210-8 · Cited by 55
Sanz‐París, A., Fernandez, M. G., Rio, L. E. H. D., Lahuerta, E. F., Monge-Vazquez, A., Callau, F. L., Sanclemente, T., Sanz-Arque, A., & Arbonés-Mainar, J. M. (2021) · Nutrients · doi:10.3390/nu13072401 · Cited by 56
Macedo, C., do Amaral, T. F., Rodrigues, J., Santin, F. G. D. O., & Avesani, C. M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.721941 · Cited by 55
Pratt, J., VITO, G. D., Segurado, R., Pessanha, L., Dolan, J., Narici, M. V., & Boreham, C. A. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12979 · Cited by 55
GDF‐15 is associated with sarcopenia and frailty in acutely admitted older medical patients
Kamper, R. S., Nygaard, H. H., Praeger‐Jahnsen, L., Ekmann, A., Ditlev, S. B., Schultz, M., Hansen, S. K., Hansen, P., Pressel, E., & Suetta, C. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13513 · Cited by 55
Screening Tools for Sarcopenia in Community-Dwellers: A Scoping Review
Nawi, S. N. M., Khow, K. S. F., Lim, W. S., & Yu, S. (2019) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v48n7p201 · Cited by 55
Borges, T. C., Gomes, T. L. N., Pichard, C., Laviano, A., & Pimentel, G. D. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.005 · Cited by 55
Liao, C., Wu, Y., Tsauo, J., Chen, P., Tu, Y., Chen, H., & Liou, T. (2020) · Nutrients · doi:10.3390/nu12082422 · Cited by 57
Ünal, N. G., Oruç, N., Tomey, O., & Özütemiz, A. Ö. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002044 · Cited by 56
Lin, T.-Y., Wu, M.-Y., Chen, H.-S., Hung, S.-C., & Lim, P.-S. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.056 · Cited by 54
Petermann-Rocha, F., Ho, F. K., Welsh, P., Mackay, D., Brown, R., Gill, J. M. R., Sattar, N., Gray, S. R., Pell, J. P., & Celis-Morales, C. A. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.04.017 · Cited by 52
Paek, J., & Choi, Y. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030938 · Cited by 55
Impact of Sarcopenia on Outcomes of Autologous Head and Neck Free Tissue Reconstruction
Jones, A. J., Alwani, M. M., Novinger, L. J., Pittelkow, E. M., Bonetto, A., Sim, M. W., Moore, M. G., & Mantravadi, A. V. (2020) · Journal of Reconstructive Microsurgery · doi:10.1055/s-0040-1701696 · Cited by 57
Oba, H., Matsui, Y., Arai, H., Watanabe, T., Iida, H., Mizuno, T., Yamashita, S., Ishizuka, S., Suzuki, Y., Hiraiwa, H., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02187-w · Cited by 55
Fukumoto, Y., Ikezoe, T., Taniguchi, M., Yamada, Y., Sawano, S., Minani, S., Asai, T., Kimura, M., & Ichihashi, N. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s304972 · Cited by 55
Griffen, C., Duncan, M. J., Hattersley, J. G., Weickert, M. O., Dallaway, A., & Renshaw, D. W. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111651 · Cited by 60
Lim, S. K., & Kong, S. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02078-z · Cited by 58
Liu, S., Ding, X., Maggiore, G., Pietrobattista, A., Satapathy, S. K., Tian, Z., & Jing, X. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1126 · Cited by 56
Ge, J., Kim, W. R., Lai, J. C., & Kwong, A. J. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.003 · Cited by 60
Sarcopenia – Definition, Radiological Diagnosis, Clinical Significance
Vogele, D., Otto, S., Sollmann, N., Haggenmüller, B., Wolf, D., Beer, M., & Schmidt, S. A. (2023) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-1990-0201 · Cited by 62
Couderc, A., Liuu, É., Boudou, P., Poisson, J., Frélaut, M., Montégut, C., Mebarki, S., Geiss, R., Thomas, Z. A., Noret, A., et al. (2023) · Nutrients · doi:10.3390/nu15051193 · Cited by 57
Post‐translational regulation of muscle growth, muscle aging and sarcopenia
Zhong, Q., Zheng, K., Li, W., An, K., Liu, Y., Xiao, X., Hai, S., Dong, B., Li, S., An, Z., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13241 · Cited by 59
“limits the daily activities of the elderly but also increases the risk of disability, hospitalization and death, placing a huge burden on society and the healthcare system.(2) Sarcopenia is”
BackgroundInfluentialImpact of sarcopenia in trauma and surgical patient population: A literature review
Wahlen, B. M., Mekkodathil, A. A., Al-Thani, H. A. S., & El-Menyar, A. A. (2019) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2019.10.010 · Cited by 57
Bulut, E. A., Soysal, P., Dokuzlar, Ö., Koçyiğit, S. E., Aydın, A. E., Yavuz, İ., & Işık, A. T. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01448-4 · Cited by 54
Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease
Saeki, C., Kanai, T., Nakano, M., Oikawa, T., Torisu, Y., Abo, M., Saruta, M., & Tsubota, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082381 · Cited by 54
Lee, J. H., Jeon, J. H., & Lee, M. J. (2020) · Nutrients · doi:10.3390/nu12092597 · Cited by 62
Dávalos‐Yerovi, V., Marco, E., Sánchez‐Rodríguez, D., Durán, X., Meza-Valderrama, D., Rodriguez, D. A., Muñoz, E., Tejero-Sánchez, M., Muns, M. D., Guillén-Solà, A., et al. (2021) · Nutrients · doi:10.3390/nu13020369 · Cited by 56
Self-citationSarcopenia and Myosteatosis Predict Adverse Outcomes After Emergency Laparotomy
Body, S., Ligthart, M. A. P., Rahman, S., Ward, J., May-Miller, P., Pucher, P. H., Curtis, N. J., & West, M. A. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000004781 · Cited by 55
Screening for Sarcopenia (Physical Frailty) in the COVID-19 Era
Ali, A. M., & Kunugi, H. (2021) · International Journal of Endocrinology · doi:10.1155/2021/5563960 · Cited by 54
Impact of Phase Angle on Physical Function in Patients with Acute Stroke
Abe, T., Yoshimura, Y., Imai, R., Yoneoka, Y., Tsubaki, A., & Sato, Y. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.105941 · Cited by 58
Takenaka, Y., Takemoto, N., Oya, R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259288 · Cited by 54
Resistance Exercise, Aging, Disuse, and Muscle Protein Metabolism
McKendry, J., Stokes, T., Mcleod, J. C., & Phillips, S. M. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200029 · Cited by 78
Phu, S., Vogrin, S., Zanker, J., Hassan, E. B., Saedi, A. A., & Duque, G. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.11.026 · Cited by 59
Suzuki, Y., Aono, Y., Kono, M., Hasegawa, H., Yokomura, K., Naoi, H., Hozumi, H., Karayama, M., Furuhashi, K., Enomoto, N., et al. (2020) · Respirology · doi:10.1111/resp.13943 · Cited by 55
Zwart, A. T., Becker, J.-N., Lamers, M. J., Dierckx, R., de Bock, G. H., Halmos, G. B., & van der Hoorn, A. (2020) · European Radiology · doi:10.1007/s00330-020-07440-1 · Cited by 53
Giné‐Garriga, M., Jerez‐Roig, J., Coll‐Planas, L., Skelton, D. A., Inzitari, M., Booth, J., & de Souza, D. L. B. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.11.010 · Cited by 62
Baltasar‐Fernandez, I., Alcázar, J., Mañas, A., Alegre, L. M., Alfaro‐Acha, A., Rodríguez‐Mañas, L., Ara, I., García‐García, F. J., & Losa‐Reyna, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-98871-3 · Cited by 53
Sarcopenia and fall-related injury among older adults in five low- and middle-income countries
Veronese, N., Smith, L., Barbagallo, M., Yang, L., Zou, L., Haro, J. M., & Koyanagi, A. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111262 · Cited by 51
Merchant, R. A., Chan, Y. H., Hui, R. J. Y., Lim, J. Y., Kwek, S. C., Seetharaman, S. K., Au, L. S. Y., & Morley, J. E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.660463 · Cited by 55
Xie, L., Jiang, J., Fu, H., Zhang, W., Yang, L. Y., & Yang, M. J. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.11.025 · Cited by 53
Ileal FXR-FGF15/19 signaling activation improves skeletal muscle loss in aged mice
Qiu, Y., Yu, J., Ji, X., Yu, H., Xue, M., Zhang, F., Li, Y., & Bao, Z. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111630 · Cited by 60
Kaegi-Braun, N., Boesiger, F., Tribolet, P., Gomes, F., Kutz, A., Hoess, C., Pavlicek, V., Bilz, S., Sigrist, S., Brändle, M., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.009 · Cited by 53
Self-citationNutritional ultrasound®: Conceptualisation, technical considerations and standardisation
García‐Almeida, J. M., García, C. G., Vegas-Aguilar, I. M., Ballesteros-Pomar, M. D., Cornejo-Pareja, I. M., Medina, B. F., de Luis, D. A., Bellido, D., Lesmes, I. B., & Tinahones, F. J. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.03.008 · Cited by 54
Mizuno, T., Hosoyama, T., Tomida, M., Yamamoto, Y., Nakamichi, Y., Kato, S., Kawai‐Takaishi, M., Ishizuka, S., Nishita, Y., Tange, C., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13102 · Cited by 55
Sarcopenia: Molecular regulatory network for loss of muscle mass and function
Wu, J., Ding, P., Wu, H., Yang, P., Guo, H., Tian, Y., Meng, L., & Zhao, Q. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1037200 · Cited by 55
Sarcopenia in Rheumatoid arthritis. A narrative review
Moschou, D., Krikelis, M. I., Georgakopoulos, C., Mole, E. N., Chronopoulos, E., Tournis, S., Mavragani, C. P., Makris, K., Dontas, I. A., & Gazi, S. (2023) · Journal of Frailty Sarcopenia and Falls · doi:10.22540/jfsf-08-044 · Cited by 53
Inflammatory biomarkers at different stages of Sarcopenia in older women
Teixeira, L. A. D. C., de Avelar, N. C. P., Dias‐Peixoto, M. F., Parentoni, A. N., dos Santos, J. M., Pereira, F. S. M., Danielewicz, A. L., Leopoldino, A. A. O., Costa, S. P., Arrieiro, A. N., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-37229-3 · Cited by 54
Frailty, Sarcopenia, Cachexia, and Malnutrition in Heart Failure
Maeda, D., Fujimoto, Y., Nakade, T., Abe, T., Ishihara, S., Jujo, K., & Matsue, Y. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0089 · Cited by 57
“28) Progressing from its predecessor, the original EWGSOP, 30) which primarily targeted individuals aged 65 and above, the revised criteria expanded the definition of sarcopenia to encompass all age groups.”
BackgroundMethodSarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features
Corallo, C., Fioravanti, A., Tenti, S., Pecetti, G., Nuti, R., & Giordano, N. G. (2019) · Rheumatology International · doi:10.1007/s00296-019-04401-w · Cited by 53
Petermann-Rocha, F. E., Chen, M., Gray, S. R., Ho, F. K. W., Pell, J. P., & Celis-Morales, C. A. (2019) · Age and Ageing · doi:10.1093/ageing/afz126 · Cited by 57
García, I. B., González-Moro, I. M., Rubio‐Arias, J. Á., & Poyatos, M. C. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16214205 · Cited by 61
Katsuki, M., Suzuki, Y., Kunitoki, K., Satō, Y., Sasaki, K., Mashiyama, S., Matsuoka, R., Allen, E., Saimaru, H., Sugawara, R., et al. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.02.033 · Cited by 53
Traub, J., Bergheim, I., Eibisberger, M., & Stadlbauer, V. (2020) · Nutrients · doi:10.3390/nu12020547 · Cited by 57
Prevalence of probable sarcopenia in community-dwelling older Swiss people – a cross-sectional study
Wearing, J., Könings, P., de Bie, R. A., Stokes, M. J., & de Bruin, E. D. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01718-1 · Cited by 53
Bakaloudi, D. R., Siargkas, A., Poulia, K., Dounousi, E. C., & Chourdakis, M. (2020) · Nutrients · doi:10.3390/nu12103071 · Cited by 58
Sehouli, J., Mueller, K., Richter, R., Anker, M. S., Woopen, H., Rasch, J., Grabowski, J., Prinz-Theissing, E., & Inci, M. G. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12676 · Cited by 53
Bahat, G. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab107 · Cited by 53
Self-citationCuyul-Vásquez, I., Pezo-Navarrete, J., Vargas-Arriagada, C., Ortega-Díaz, C., Sepúlveda-Loyola, W., Hirabara, S. M., & Marzuca-Nassr, G. N. (2023) · Nutrients · doi:10.3390/nu15153424 · Cited by 56
“consensus of EWGSOP [1] or AWGSOP [27]), with or without concomitant diseases; (2) intervention: addition of supplements based on concentrated, isolated, or hydrolyzed WP during RET; RET was considered when the program training used machines, elastic bands, or free weights with moderate to high intensity (equal to or…”
BackgroundMethodInfluentialAckermans, L. L. G. C., Volmer, L., Wee, L., Brecheisen, R., González, P. S., Seiffert, A. P., Aguilera, E. J. G., Dekker, A. L. A. J., Bosch, J. A. T., Damink, S. W. M. O., et al. (2021) · Sensors · doi:10.3390/s21062083 · Cited by 51
Yamada, Y., Yamada, M., Yoshida, T., Miyachi, M., & Arai, H. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12732 · Cited by 59
Margiotta, E., Caldiroli, L., Callegari, M. L., Miragoli, F., Zanoni, F., Armelloni, S., Rizzo, V., Messa, P., & Vettoretti, S. (2021) · Toxins · doi:10.3390/toxins13070472 · Cited by 57
Malnutrition-sarcopenia syndrome and all-cause mortality in hospitalized older people
Gümüşsoy, M., Atmış, V., Yalçın, A., Bahşi, R., Yiğit, S., Arı, S., Dokuyan, H. C., Gözükara, M. G., & Sılay, K. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.09.036 · Cited by 52
Tan, L., Ji, G., Bao, T., Fu, H., Yang, L. Y., & Yang, M. J. (2021) · Insights into Imaging · doi:10.1186/s13244-021-01106-2 · Cited by 53
Sarcopenia: early prevention or overdiagnosis?
Haase, C. B., Brodersen, J., & Bülow, J. (2022) · BMJ · doi:10.1136/bmj-2019-052592 · Cited by 52
Assessment of Muscle Quantity, Quality and Function
Koo, B. K. (2022) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes22025 · Cited by 56
Minniti, G., Pescinini-Salzedas, L. M., Minniti, G. A. D. S., Laurindo, L. F., Barbalho, S. M., Sinatora, R. V., Sloan, L. A., Haber, R. S. D. A., Araújo, A. C., Quesada, K. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113452 · Cited by 53
Granic, A., Hurst, C., Dismore, L. L., Dodds, R. M., Witham, M. D., Robinson, S. M., & Sayer, A. A. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111744 · Cited by 58
Self-citationJacob, L., Gyasi, R. M., Oh, H. Y., Smith, L., Kostev, K., Sánchez, G. F. L., Rahmati, M., Haro, J. M., Tully, M. A., Shin, J. I., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13215 · Cited by 52
Whaikid, P., & Piaseu, N. (2024) · Epidemiology and Health · doi:10.4178/epih.e2024030 · Cited by 52
“Sarco-penia, a prevalent condition associated with aging, is characterized by the progressive loss of skeletal muscle mass and strength, which impacts physical performance [3].”
BackgroundObstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives
Ooi, H., & Welch, C. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s438144 · Cited by 57
Pathways in formulating foods for the elderly
Qin, Y., Pillidge, C. J., Harrison, B., & Adhikari, B. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114324 · Cited by 55
Yin, K., Chen, T., Gu, X., Su, W., Jiang, Z., Lu, S., Cao, B., Chi, L., Gao, X., & Chen, Y. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13479 · Cited by 53
Liu, Z., Guo, Y., & Zheng, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1375610 · Cited by 64
Kerr, H. L., Krumm, K., Anderson, B., Christiani, A. J., Strait‐Bodey, L., Li, T., Irwin, B., Jiang, S., Rybachok, A., Chen, A. L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172890 · Cited by 57
“In 2018, the same group revised this consensus definition for clinical diagnosis (known as EWGSOP2), prioritizing muscle function over muscle mass as the primary parameter for sarcopenia (19).”
InfluentialLees, M. J., Wilson, O. J., Hind, K., & Ispoglou, T. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04107-8 · Cited by 50
Metadata
- Authors
- Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., Schneider, S. M., Sieber, C. C., Topinkova, E., Vandewoude, M., Visser, M., Zamboni, M., Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), A. T. E. G. F. E., Bautmans, I., Baeyens, J.-P., Cesari, M., Cherubini, A., Kanis, J., Maggio, M., Martin, F., Michel, J.-P., Pitkala, K., Reginster, J.-Y., Rizzoli, R., Sánchez-Rodríguez, D., & Schols, J.
- Affiliations
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Istanbul University (TR)
- Heidelberg University (DE)
- Research Department, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
- University of Liège (BE)
- Uppsala University (SE)
- University of Oxford (GB)
- Università Cattolica del Sacro Cuore (IT)
- Université de Toulouse (FR)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Université Côte d'Azur (FR)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Department of Geriatrics, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic
- University of Antwerp (BE)
- Amsterdam Public Health (NL)
- University of Verona (IT)
- University of Geneva (CH)
- Vrije Universiteit Brussel (BE)
- University of Luxembourg (LU)
- University of Milan (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Parma (IT)
- Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Central Hospital, Unit of Primary Health Care; Helsinki, Finland
- Geriatrics Department, Parc Salut Mar. Rehabilitation Research Group, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM). Universitat Autònoma de Barcelona, Universitat Pompeu Fabra; Barcelona, Spain
- Maastricht University (NL)
- Corresponding author
- Cruz-Jentoft, Alfonso J
- ORCID
- Cruz-Jentoft, Alfonso J
- Bahat, Gülistan
- Bauer, Jürgen
- Bruyère, Olivier
- Cederholm, Tommy
- Cooper, Cyrus
- Landi, Francesco
- Rolland, Yves
- Sayer, Avan Aihie
- Schneider, Stéphane M
- Sieber, Cornel C
- Vandewoude, Maurits
- Visser, Marjolein
- Zamboni, Mauro
- Bautmans, Ivan
- Baeyens, Jean-Pierre
- Cesari, Matteo
- Cherubini, Antonio
- Kanis, John
- Maggio, Marcello
- Martin, Finbarr
- Michel, Jean-Pierre
- Reginster, Jean-Yves
- Rizzoli, René
- Schols, Jos
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-09-24
- Volume
- 48
- Issue
- 1
- Pages
- 16-31
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC6322506
- OpenAlex
- W2897513125
- Semantic Scholar
- ccbd36e412f2f03b0db9d7628ea646fb57c093c9
- Cited by
- 13,818
- References
- 156
- Citations by year
- 2026: 1514 · 2025: 2382 · 2024: 2262 · 2023: 2122 · 2022: 1909 · 2021: 1759 · 2020: 1234 · 2019: 580 · 2018: 25
- FWCI
- 616.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- VU Research Portal (publishedVersion, other-oa)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by-nc)
- Työväentutkimus Vuosikirja (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Lirias (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- European Working Group on Sarcopenia in Older People 2
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- sarcopenia, sarcopenia definitions, sarcopenia diagnosis, muscle weakness, muscle mass, muscle quality, physical performance, sarcopenia severity, case-finding algorithms, cut-off values, older adults, EWGSOP2 criteria
- MeSH terms
- Europe, Humans, Biomarkers, Muscle, Skeletal, Biomedical Research, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
